Table 6.
Genetic polymorphism or mutation | No. screened | No. positive (%) |
---|---|---|
Apolipoprotein E –ε4 | 1302 | 524 (40) |
LRRK2 – G2019S polymorphism screened | 237 | 3 (1.3) |
Glucocerebrosidase (GBA) – all exons screened | 247 | 18 (7.3) |
Tau (MAPT) – screen of exons 1 and 9–13 | 45 | 3 (1.3) |
Presenilin 1 – mutation screen | 7 | 4 (57) |
Progranulin (GRN) – screen of exons 1–13 | 31 | 4 (12.9) |
C9orf72 – expansion screen | 21 | 5 (24) |
TDP43 (TARDBP) | 1 | 0 |
Valosin-containing protein (VCP) | 1 | 0 |
Charged multivesicular body protein 2B (CHMP2B) | 1 | 0 |